We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current SEEL market cap is 4.24M. The company's latest EPS is USD -2.7690 and P/E is -0.11.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 808k | 336k | 406k |
| Operating Income | -17.41M | -18.26M | -8.93M | -10.95M | -12.6M |
| Net Income | -19.6M | -18.66M | -13.43M | -29.5M | 10.5M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 375k | 0 | 0 | 0 | 2.2M |
| Operating Income | -29.75M | -18.76M | -61.67M | -70.92M | -40.5M |
| Net Income | -51.26M | -19.1M | -66.05M | -73.53M | -37.88M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 40.51M | 22.75M | 23.64M | 11.89M | 6.22M |
| Total Liabilities | 32.63M | 33.36M | 44.3M | 59.07M | 36.63M |
| Total Equity | 7.88M | -10.61M | -20.66M | -47.18M | -30.41M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 11.1M | 17.49M | 83.5M | 22.75M | 5.42M |
| Total Liabilities | 11.1M | 14.92M | 26.18M | 33.36M | 38.93M |
| Total Equity | -7k | 2.57M | 57.32M | -10.61M | -33.51M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -48.51M | -61.6M | -10.35M | -16.25M | -22M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 291k | -1.6M | 8.87M | 6.56M | 9.05M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -19.31M | -20.91M | -49M | -61.6M | -23.91M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 29.52M | 26.31M | 112.07M | -1.6M | 11.38M |
| Market Cap | 4.24M |
| Price to Earnings Ratio | -0.11 |
| Price to Sales Ratio | 1.93 |
| Price to Cash Ratio | 1.42 |
| Price to Book Ratio | -0.13 |
| Dividend Yield | - |
| Shares Outstanding | 13.68M |
| Average Volume (1 week) | 426.55k |
| Average Volume (1 Month) | 409.58k |
| 52 Week Change | -98.47% |
| 52 Week High | 49.80 |
| 52 Week Low | 0.2705 |
| Spread (Intraday) | 0.02 (5.36%) |
| Company Name | Seelos Therapeutics Inc |
| Address |
c t corporation system carson city, nevada 89701 |
| Website | https://seelostherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
